Generac Holdings Inc. GNRC expects to generate approximately $350 million in free cash flow in 2026, even as it increases capital spending to expand production capacity and capitalize on growing demand for backup power …
Read more →Join over half a million readers using Kiplinger's insights to make smart financial decisions. Profit and prosper with our expert guidance on investing, taxes and retirement, and more. Delivered daily.
Read more →A group of investors led by Nelson Peltz's Trian Fund Management has offered $1.4 billion to buy Wendy's, according to a regulatory filing Wednesday.
Read more →The Federal Election Commission said Tuesday night that it identified the issue affecting its electronic filing system and was implementing a fix, after reports that a hacker or hackers had targeted the agency's systems…
Read more →August 5, 2026, 3:53 AM EDT.IPOs such as SpaceX and ChangXin Memory Technologies have generated worldwide interest, particularly across the tech and AI sectors. Still, with founders trying to maximize returns and invest…
Read more →Shares of Stellantis were up Wednesday as the European car giant's third-quarter results showed it was making progress with its 60 billion euro turnaround plan.
Read more →The "Magnificent Seven" doesn't trade as a monolith anymore, challenging investors to be more discerning when picking through the market's biggest stocks rather than viewing them as a single trade.
Read more →At least 64 people have been killed in a collision between two trains in the Spanish province of Toledo.
Read more →Jim Cramer's top 10 things to watch in the stock market Wednesday SK Hynix blew away the numbers, and GE Vernova crushed it too. Read at source
Read more →What are the best stocks to buy right now? There are thousands of publicly traded companies you can invest in. That doesn't even include the many exchange-traded funds (ETFs) and mutual funds you can buy. So it's not su…
Read more →British pharma company reports declining profits amid weaker vaccine sales and looming patent loss for blockbuster HIV drug
Read more →Google has spent years pitching customers on the advantage of buying its chips, models and cloud services in one place, offering a full stack that rivals Amazon and Microsoft have tried to replicate.
Read more →Budget 2026: six charts that reveal the economic realities facing the chancellor
Read more →Elevator manufacturer Otis (NYSE:OTIS) will be reporting earnings this Wednesday before market hours. Hereâs what to expect.
Read more →Investors are pricing in a higher likelihood that the Federal Reserve will hike rates after core CPI inflation rose in August more than economists had estimated. However, a rate hike may not keep the US stock market fro…
Read more →The benchmark KOSPI rose 337.64 points, or 5.99%, to 5,975.98 as of 0140 GMT. If the gains hold, the index would record its biggest single-day percentage rise since July 31, as per the report.
Read more →UBS reported a pre-tax profit of almost $3.6 billion in the third quarter, up 27% year on year, largely in line with consensus forecasts.
Read more →Samsung Electro-Mechanics (009150.KS) shares rocketed to their daily price limit early in the session. The surge was fueled by a concentrated wave of buying after the company reported second-quarter earnings that blew p…
Read more →Oil prices climbed Wednesday as investors weighed the prospect of a prolonged and widening Middle East conflict after Tehran-backed Houthis attacked Saudi Arabia's largest refinery.
Read more →Jio Platforms' shares rose 21.4% on their trading debut Wednesday after a record initial public offering that was lapped up by retail as well as institutional investors.
Read more →President Donald Trump joked that the $5,000 payments he's promised U.S. adults would buy little more than "a hamburger and maybe a small dessert" at his Mar-a-Lago club in Florida, a week before midterm elections domin…
Read more →The loan-satisfaction agreements exchange debt for convertible preferred shares and warrants, with conversion and exercise subject to shareholder approval.
Read more →WAYNE, Pa., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today …
Read more →CBIZ stockholders preliminarily approved the proposed merger with Viking ParentCo and Viking MergerCo at a special meeting.
Read more →